Clinical and radiological diagnosis of non–SARS‐CoV‐2 viruses in the era of COVID‐19 pandemic

INTRODUCTION Following the announcement of first coronavirus disease 2019 (COVID‐19) case on March 11, 2020, in Turkey we aimed to report the co‐infection rates, and the clinical, laboratory, radiological distinctive features of viral pneumonia caused by viruses other than severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). METHODS A cross‐sectional study was conducted between 18 and 31 March 2020. COVID‐19 suspected cases admitted to pandemic policlinic who had nasopharyngeal swab specimens tested for both SARS‐CoV‐2 and other respiratory viral pathogens were included. RESULTS Within 112 patients SARS‐CoV‐2 was detected in 34 (30%). Among the non‐SARS‐CoV‐2 viruses (n=25, 22%), metapneumovirus (n=10), was the most frequent agent. There were two co‐infections with SARS‐CoV‐2. Sputum was less in the SARS‐CoV‐2 group (p=0.003). The leukocyte, lymphocyte, and thrombocyte count and C‐reactive protein levels were lowest in the SARS‐CoV‐2 group (p